title: Orbital signet-ring cell lymphoma of diffuse, large, B-cell type.
authors: Kaustubh
authors: K
authors: Mulay
authors: Ophthalmic Pathology Service, L.V. Prasad Eye Institute; National Reporting Centre for Ophthalmic Pathology, Centre For Sight. Electronic address: kaustubh.m@hotmail.com.
authors: Mulay
authors: M
authors: Kaustubh
authors: Akshay G
authors: AG
authors: Nair
authors: Ekta
authors: E
authors: Aggarwal
authors: Valerie A
authors: VA
authors: White
authors: Santosh G
authors: SG
authors: Honavar
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D061766:Proton Therapy; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014408:Biomarkers, Tumor; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone